Skip to Content

CloniBID Approval Status

FDA Approved: No
Brand name: CloniBID
Generic name: clonidine hydrochloride
Company: Addrenex Pharmaceuticals, Inc.
Treatment for: High Blood Pressure

CloniBID is a 12-hour, sustained-release formulation of the centrally acting alpha-2 agonist clonidine hydrochloride under review for the treatment of hypertension.

Development Status and FDA Approval Process for CloniBID

DateArticle
Apr 22, 2008Sciele Pharma Announces FDA Acceptance of NDA for Addrenex Pharmaceuticals' CloniBID to Treat Hypertension
Feb 20, 2008Addrenex Pharmaceuticals Reaches Milestone with Filing of NDA for First Product, CloniBID, to Treat Hypertension

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide